Ernest L. Stadler, P.E.
Ernest L. Stadler is Founder and CEO of New Horizon Biotech, Inc. a start-up focused on innovative single use microbial fermentation and cell culture bioreactor technology.
Mr. Stadler has broad based expertise in automation, process and mechanical design for a wide range of Bioprocess equipment having served the biotechnology industry for over 30 years.
He has been a frequent speaker, teacher, and workshop leader on the design and application of fermentors and bioreactors particularly relating to biotechnology process scale-up and optimizing performance. Ernest served as Course Director, Lecturer and Workshop Leader for over 12 years with the ASME BioProcessing Technology Seminar series. He had served for 5 years on the Board of Directors for the SBP being a founding member and Treasurer. He has authored technical articles and papers and was awarded the 1998 Article of the Year by Pharmaceutical Engineering Magazine, a publication of the ISPE.
He previously consulted on bioreactors and fermentor technology as Senior Consultant at Stadler Engineering Co. Earlier career positions were as Director of Custom Bioprocess Systems at Sartorius Stedim Systems, Inc, a manufacturer of fermentors, bioreactors, automation software / hardware, and other related bioprocess laboratory and custom large scale equipment.
A member of ASME and ISPE, Mr. Stadler is a registered Professional Engineer in PA and NJ, holding a BS in Mechanical Engineering from NJIT and has done graduate studies at Lehigh University in biotechnology.
He continues to pioneer with the newly formed NHB, Inc. leading the new paradigm for horizontal modular SU fermentors and bioreactors to offer the industry great flexibility in scale-up while permitting large scale equipment to fit into 9’ to 10’ ceiling height modular and podular clean room construction.
Dwight M. Rose, BSChE
Dwight M. Rose is Director of Operations at New Horizon Biotech (NHB), Inc. a start-up corporation focused on innovative single use microbial fermentation and cell culture bioreactor technology.
Mr. Rose has over 40 years of experience in a wide range of engineering and manufacturing experiences. Mr. Rose spent more than 30 years with Ingersoll Rand’s pump divisions in various engineering and service positions. He served as worldwide Manager of After Market Engineering and Services.
Recently he served as President of Rotating Technology Services, Inc. a worldwide pump and flow control design and repair service organization.
Mr. Rose has done extensive consulting work with U.S. steel and chemical manufactures as well as the U.S. Nuclear Regulatory Commission (NRC).
Mr. Rose continues to add his extensive knowledge and business experience with the newly formed NHB, Inc. leading the new paradigm for horizontal modular SU fermentors and bioreactors.
Janice Phillips, PhD
Dr. Janice A. Phillips is Director of Technology at New Horizon Biotech (NHB), Inc. a start-up corporation focused on innovative single use microbial fermentation and cell culture bioreactor technology.
Dr. Phillips has over 35 years of biotechnology experience, focusing on microbial and mammalian cell culture systems. Most recently she served as Head, Technical Operations for WindMIL Therapeutics, Inc., an early clinical stage cell therapy company. Prior to joining WindMIL, she served as VP, Product Development for the biosimilars group at Dr. Reddy’s Laboratories, Inc.
She has held the positions of VP, Product Development and Executive Director, Manufacturing Sciences & Technology at Auxilium Pharmaceuticals, Inc., Executive Director, Manufacturing Technology at Tengion, Inc., and served in various capacities for Centocor/J&J following a nineteen year tenure on the faculty of the Department of Chemical Engineering at Lehigh University, where she held a variety of administrative positions. Dr. Phillips received her B.Ch.E degree from Villanova University and her M.S. and PhD. degrees in Chemical & Biochemical Engineering from the University of Pennsylvania.